Mirati Therapeutics, Inc.

GOLDMAN SACHS GROUP INC

Report date

12/31/2023

Quarter

2023 Q4

Filed

5/14/2024

Shares

75,233

Value ($000)

4,420

Weight

0.0%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	5/14/2024	4,420	0.0%	75,233	12/31/2023
2023 Q3	5/15/2024	1,525	0.0%	34,999	9/30/2023
2023 Q2	5/14/2024	1,487	0.0%	41,155	6/30/2023
2023 Q1	5/14/2024	1,776	0.0%	47,762	3/31/2023
2022 Q4	5/14/2024	13,262	0.0%	292,698	12/31/2022
2022 Q3	5/14/2024	15,243	0.0%	218,258	9/30/2022
2022 Q2	5/14/2024	164,298	0.0%	2,447,460	6/30/2022
2022 Q1	5/16/2022	10,574	0.0%	128,607	3/31/2022
2021 Q4	2/17/2022	34,193	0.0%	233,099	12/31/2021
2021 Q3	1/20/2022	34,709	0.0%	196,196	9/30/2021
2021 Q2	8/13/2021	28,833	0.0%	178,504	6/30/2021
2021 Q1	5/17/2021	70,822	0.0%	413,439	3/31/2021
2020 Q4	2/12/2021	104,988	0.0%	478,000	12/31/2020
2020 Q3	11/13/2020	93,006	0.0%	560,103	9/30/2020
2020 Q2	8/12/2020	43,252	0.0%	378,842	6/30/2020
2020 Q1	5/15/2020	34,233	0.0%	445,330	3/31/2020
2019 Q4	2/14/2020	41,400	0.0%	321,286	12/31/2019
2014 Q1	5/15/2014	542	0.0%	28,447	3/31/2014
2013 Q4	2/14/2014	446	0.0%	26,847	12/31/2013